An update on the role of PET/CT and PET/MRI in ovarian cancer.
Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, Werner TJ, Alavi A.
Khiewvan B, et al.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1079-1091. doi: 10.1007/s00259-017-3638-z. Epub 2017 Feb 8.
Eur J Nucl Med Mol Imaging. 2017.
PMID: 28180966
Review.
Although PET/CT staging is superior for N and M staging of ovarian cancer, its role is limited for T staging. Additionally, FDG PET/CT is of great benefit in evaluating treatment response and has prognostic value in patients with ovarian cancer. ...
Although PET/CT staging is superior for N and M staging of ovarian cancer, its role is limited for T staging. Additionally, FDG PET/C …